Angelica Mariani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Angelica Mariani has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Raphaël Rodriguez
Institut Curie, CNRS, INSERM, PSL Research University, Paris, France
6 shared publications - John D. Sutherland
MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, United Kingdom
4 shared publications Christophe Ginestier
Université Aix-Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Epithelial Stem Cells and Cancer Team, Marseille, France
2 shared publicationsCorey Nislow
Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada
2 shared publications- David A. Russell
MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, U.K.
2 shared publications Emmanuelle Charafe-Jauffret
Genome Technology Center, Stanford School of Medicine, Stanford, CA, USA
2 shared publications
Latest Publications
- Open Access
- 2 October 2020
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 11 (39) , 10688-10697
Activation chemistry drives the emergence of functionalised protocells
The complexity of the simplest conceivable cell suggests that the chemistry of prebiotic mixtures needs to be explored to understand the intricate network of prebiotic reactions that led to the emergence of life.
- 2 October 2020
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 11 (39) , 10688-10697
Open AccessActivation chemistry drives the emergence of functionalised protocells
The complexity of the simplest conceivable cell suggests that the chemistry of prebiotic mixtures needs to be explored to understand the intricate network of prebiotic reactions that led to the emergence of life.
- 4 March 2019
- Published by Springer Nature in Nature Chemical Biology
- Vol. 15 (5) , 549
Publisher Correction: PH-domain-binding inhibitors of nucleotide exchange factor BRAG2 disrupt Arf GTPase signaling
In the version of this article originally published, several co-authors had incorrect affiliation footnote numbers listed in the author list. Tatiana Cañeque and Angelica Mariani should each have affiliation numbers 3, 4 and 5, and Emmanuelle Charafe-Jauffret should have number 6. Additionally, there was an extra space in the name of co-author Robert P. St.Onge. These errors have been corrected in the HTML and PDF versions of the paper and the Supplementary Information PDF.
- 4 March 2019
- Published by Springer Nature in Nature Chemical Biology
- Vol. 15 (5) , 549
Publisher Correction: PH-domain-binding inhibitors of nucleotide exchange factor BRAG2 disrupt Arf GTPase signaling
In the version of this article originally published, several co-authors had incorrect affiliation footnote numbers listed in the author list. Tatiana Cañeque and Angelica Mariani should each have affiliation numbers 3, 4 and 5, and Emmanuelle Charafe-Jauffret should have number 6. Additionally, there was an extra space in the name of co-author Robert P. St.Onge. These errors have been corrected in the HTML and PDF versions of the paper and the Supplementary Information PDF.
- 11 February 2019
- Published by Springer Nature in Nature Chemical Biology
- Vol. 15 (4) , 358-366
PH-domain-binding inhibitors of nucleotide exchange factor BRAG2 disrupt Arf GTPase signaling
Peripheral membrane proteins orchestrate many physiological and pathological processes, making regulation of their activities by small molecules highly desirable. However, they are often refractory to classical competitive inhibition. Here, we demonstrate that potent and selective inhibition of peripheral membrane proteins can be achieved by small molecules that target protein–membrane interactions by a noncompetitive mechanism. We show that the small molecule Bragsin inhibits BRAG2-mediated Arf GTPase activation in vitro in a manner that requires a membrane. In cells, Bragsin affects the trans-Golgi network in a BRAG2- and Arf-dependent manner. The crystal structure of the BRAG2–Bragsin complex and structure–activity relationship analysis reveal that Bragsin binds at the interface between the PH domain of BRAG2 and the lipid bilayer to render BRAG2 unable to activate lipidated Arf. Finally, Bragsin affects tumorsphere formation in breast cancer cell lines. Bragsin thus pioneers a novel class of drugs that function by altering protein–membrane interactions without disruption.
- 11 February 2019
- Published by Springer Nature in Nature Chemical Biology
- Vol. 15 (4) , 358-366
PH-domain-binding inhibitors of nucleotide exchange factor BRAG2 disrupt Arf GTPase signaling
Peripheral membrane proteins orchestrate many physiological and pathological processes, making regulation of their activities by small molecules highly desirable. However, they are often refractory to classical competitive inhibition. Here, we demonstrate that potent and selective inhibition of peripheral membrane proteins can be achieved by small molecules that target protein–membrane interactions by a noncompetitive mechanism. We show that the small molecule Bragsin inhibits BRAG2-mediated Arf GTPase activation in vitro in a manner that requires a membrane. In cells, Bragsin affects the trans-Golgi network in a BRAG2- and Arf-dependent manner. The crystal structure of the BRAG2–Bragsin complex and structure–activity relationship analysis reveal that Bragsin binds at the interface between the PH domain of BRAG2 and the lipid bilayer to render BRAG2 unable to activate lipidated Arf. Finally, Bragsin affects tumorsphere formation in breast cancer cell lines. Bragsin thus pioneers a novel class of drugs that function by altering protein–membrane interactions without disruption.
- Open Access
- 25 July 2018
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 9 (35) , 7053-7057
Tuning the reactivity of nitriles using Cu(ii) catalysis – potentially prebiotic activation of nucleotides
During the transition from prebiotic chemistry to biology, a period of solution-phase, non-enzymatic activation of (oligo)nucleotides must have occurred, and accordingly, a mechanism for phosphate activation must have existed. Herein, we detail results of an investigation into prebiotic phosphate activation chemistry using simple, prebiotically available nitriles whose reactivity is increased by Cu2+ ions. Furthermore, although Cu2+ ions are known to catalyse the hydrolysis of phosphodiester bonds, we found this deleterious activity to be almost completely suppressed by inclusion of amino acids or dipeptides, which may suggest a productive relationship between protein and RNA from the outset.
- 25 July 2018
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 9 (35) , 7053-7057
Open AccessTuning the reactivity of nitriles using Cu(ii) catalysis – potentially prebiotic activation of nucleotides
During the transition from prebiotic chemistry to biology, a period of solution-phase, non-enzymatic activation of (oligo)nucleotides must have occurred, and accordingly, a mechanism for phosphate activation must have existed. Herein, we detail results of an investigation into prebiotic phosphate activation chemistry using simple, prebiotically available nitriles whose reactivity is increased by Cu2+ ions. Furthermore, although Cu2+ ions are known to catalyse the hydrolysis of phosphodiester bonds, we found this deleterious activity to be almost completely suppressed by inclusion of amino acids or dipeptides, which may suggest a productive relationship between protein and RNA from the outset.
- Open Access
- 2 July 2018
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 140 (28) , 8657-8661
A Light-Releasable Potentially Prebiotic Nucleotide Activating Agent
Investigations into the chemical origin of life have recently benefitted from a holistic approach in which possible atmospheric, organic, and inorganic systems chemistries are taken into consideration. In this way, we discovered and now report that a selective phosphate activating agent, namely methyl isocyanide, could plausibly have been produced from simple prebiotic feedstocks. We show that methyl isocyanide drives the conversion of nucleoside monophosphates to phosphorimidazolides under potentially prebiotic conditions and in excellent yields for the first time. Importantly, this chemistry allows for repeated re-activation cycles, a property long sought in non-enzymatic oligomerization studies. Further, as the isocyanide is released upon exposure to light, the possibility of spatially and temporally controlled activation chemistry is thus raised.
- 2 July 2018
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 140 (28) , 8657-8661
Open AccessA Light-Releasable Potentially Prebiotic Nucleotide Activating Agent
Investigations into the chemical origin of life have recently benefitted from a holistic approach in which possible atmospheric, organic, and inorganic systems chemistries are taken into consideration. In this way, we discovered and now report that a selective phosphate activating agent, namely methyl isocyanide, could plausibly have been produced from simple prebiotic feedstocks. We show that methyl isocyanide drives the conversion of nucleoside monophosphates to phosphorimidazolides under potentially prebiotic conditions and in excellent yields for the first time. Importantly, this chemistry allows for repeated re-activation cycles, a property long sought in non-enzymatic oligomerization studies. Further, as the isocyanide is released upon exposure to light, the possibility of spatially and temporally controlled activation chemistry is thus raised.
- Open Access
- 3 May 2017
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 56 (23) , 6563-6566
Non‐Enzymatic RNA Backbone Proofreading through Energy‐Dissipative Recycling
Non‐enzymatic oligomerization of activated ribonucleotides leads to ribonucleic acids that contain a mixture of 2′,5′‐ and 3′,5′‐linkages, and overcoming this backbone heterogeneity has long been considered a major limitation to the prebiotic emergence of RNA. Herein, we demonstrate non‐enzymatic chemistry that progressively converts 2′,5′‐linkages into 3′,5′‐linkages through iterative degradation and repair. The energetic costs of this proofreading are met by the hydrolytic turnover of a phosphate activating agent and an acylating agent. With multiple rounds of this energy‐dissipative recycling, we show that all‐3′,5′‐linked duplex RNA can emerge from a backbone heterogeneous mixture, thereby delineating a route that could have driven RNA evolution on the early earth.
- 3 May 2017
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 56 (23) , 6563-6566
Open AccessNon‐Enzymatic RNA Backbone Proofreading through Energy‐Dissipative Recycling
Non‐enzymatic oligomerization of activated ribonucleotides leads to ribonucleic acids that contain a mixture of 2′,5′‐ and 3′,5′‐linkages, and overcoming this backbone heterogeneity has long been considered a major limitation to the prebiotic emergence of RNA. Herein, we demonstrate non‐enzymatic chemistry that progressively converts 2′,5′‐linkages into 3′,5′‐linkages through iterative degradation and repair. The energetic costs of this proofreading are met by the hydrolytic turnover of a phosphate activating agent and an acylating agent. With multiple rounds of this energy‐dissipative recycling, we show that all‐3′,5′‐linked duplex RNA can emerge from a backbone heterogeneous mixture, thereby delineating a route that could have driven RNA evolution on the early earth.
- 24 November 2015
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 52 (7) , 1358-1360
Iron-dependent lysosomal dysfunction mediated by a natural product hybrid
Artesumycin is a fluorescent hybrid of the natural products marmycin A and artemisinin. It was designed to combine the lysosomotropic properties of the angucycline and the iron-reactive capacity of the endoperoxide to target the lysosomal compartment of cancer cells. Herein, we show that artesumycin inhibits cancer cell proliferation in an iron-dependent manner and chemically fragments in vitro in the presence of redox-active iron(II). Visual detection of artesumycin by fluorescence microscopy provided substantial evidence that the small molecule selectively targets lysosomes. This original approach based on a fluorescent and iron-reactive probe represents a powerful strategy for initiating and, concomitantly, visualizing lysosomal dysfunction in human cells.
- 24 November 2015
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 52 (7) , 1358-1360
Iron-dependent lysosomal dysfunction mediated by a natural product hybrid
Artesumycin is a fluorescent hybrid of the natural products marmycin A and artemisinin. It was designed to combine the lysosomotropic properties of the angucycline and the iron-reactive capacity of the endoperoxide to target the lysosomal compartment of cancer cells. Herein, we show that artesumycin inhibits cancer cell proliferation in an iron-dependent manner and chemically fragments in vitro in the presence of redox-active iron(II). Visual detection of artesumycin by fluorescence microscopy provided substantial evidence that the small molecule selectively targets lysosomes. This original approach based on a fluorescent and iron-reactive probe represents a powerful strategy for initiating and, concomitantly, visualizing lysosomal dysfunction in human cells.
- 20 May 2015
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 58 (11) , 4851-4856
Differential Targeting of Human Topoisomerase II Isoforms with Small Molecules
The TOP2 poison etoposide has been implicated in the generation of secondary malignancies during cancer treatment. Structural similarities between TOP2 isoforms challenge the rational design of isoform-specific poisons to further delineate these processes. Herein, we describe the synthesis and biological evaluation of a focused library of etoposide analogues, with the identification of two novel small molecules exhibiting TOP2B-dependent toxicity. Our findings pave the way toward studying isoform-specific cellular processes by means of small molecule intervention.
- 20 May 2015
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 58 (11) , 4851-4856
Differential Targeting of Human Topoisomerase II Isoforms with Small Molecules
The TOP2 poison etoposide has been implicated in the generation of secondary malignancies during cancer treatment. Structural similarities between TOP2 isoforms challenge the rational design of isoform-specific poisons to further delineate these processes. Herein, we describe the synthesis and biological evaluation of a focused library of etoposide analogues, with the identification of two novel small molecules exhibiting TOP2B-dependent toxicity. Our findings pave the way toward studying isoform-specific cellular processes by means of small molecule intervention.
- 1 August 2014
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 22 (16) , 4474-4489
Biased and unbiased strategies to identify biologically active small molecules
- 1 August 2014
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 22 (16) , 4474-4489
Biased and unbiased strategies to identify biologically active small molecules
- Open Access
- 4 April 2014
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 12 (22) , 3744-3754
Aryl ethynyl anthraquinones: a useful platform for targeting telomeric G-quadruplex structures
Aryl ethynyl anthraquinones have been synthesized by Sonogashira cross-coupling and evaluated as telomeric G-quadruplex ligands, by the FRET melting assay, circular dichroism, the DNA synthesis arrest assay and molecular docking. Both the binding properties and G-quadruplex vs. duplex selectivity are controlled by the structures of the aryl ethynyl moieties.
- 4 April 2014
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 12 (22) , 3744-3754
Open AccessAryl ethynyl anthraquinones: a useful platform for targeting telomeric G-quadruplex structures
Aryl ethynyl anthraquinones have been synthesized by Sonogashira cross-coupling and evaluated as telomeric G-quadruplex ligands, by the FRET melting assay, circular dichroism, the DNA synthesis arrest assay and molecular docking. Both the binding properties and G-quadruplex vs. duplex selectivity are controlled by the structures of the aryl ethynyl moieties.